<DOC>
	<DOCNO>NCT02806804</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity quadrivalent influenza virus vaccine healthy people age year 3-60.Subjects randomly divide 3 group , receive test vaccine , commercially available trivalent influenza vaccine trivalent influenza vaccine contain new influenza B component respectively . Each group 800 subjects,2400 total .</brief_summary>
	<brief_title>Safety Immunogenicity Study Quadrivalent Influenza Virus Vaccine Healthy People Aged Years 3-60</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>healthy subject 3 year old , subject informed consent , sign inform consent . subject guardians obey demand scheme . Axillary temperature le 37℃ The people flu influenzalike symptom ( fever &lt; axillary temperature ≥38 ℃ &gt; , cough sore throat ) within 3 month The people vaccinate influenza vaccine 3years . The people vaccine allergy , allergic kind composition experimental vaccine , egg , ovalbumin etc . The people serious side effect vaccine , allergy , urticaria , skin eczema , dyspnea , angioneurotic edema abdominal pain . subject symptom acute infection within week . Autoimmune diseases Immune function defect , people immunosuppressive therapy , cytotoxic treatment inhale corticosteroid past 6 month . People congenital malformation , developmental disorder serious chronic disease ( Down 's syndrome , diabetes , Sickle cell anemia nerve system disease ) People asthma Unstable need emergency treatment , hospitalization , intubation , oral intravenous corticosteroid past 2 year . Diagnosed abnormal coagulation ( Lack clot factor , Clotting disorder , Platelet abnormality ) significant bruise coagulopathy people history family history convulsion , seizure , encephalopathy psychiatric . alienia , functional asplenia , alienia splenectomy situation . Serious neurological disorder Green Barry syndrome . people receive blood product immunoglobulin product past one month . people receive study drug past one month . people receive live attenuated vaccine , subunit vaccine inactivate vaccine . people receive allergy treatment past 14 day . People antiTB treatment . People whose axillary temperature 37℃ vaccination . People pregnant . Any factor unsuitable clinical trail accord researcher .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>vaccine</keyword>
	<keyword>safety</keyword>
	<keyword>immunogenicity</keyword>
</DOC>